CD38 and COVID-19: In line with others, we find that the ILC2 from severe COVID-19 patients show a more activated phenotype in terms of CD38, CD69 and a trend for NKG2D expression; the latter marker was already shown to be upregulated in patients showing no need for mechanical ventilation and a shorter hospitalization (63).